Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19151,137,1.00 [0.85-1.17],0.9961102033443928
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19978,153,1.03 [0.88-1.19],0.7308568022132866
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19775,1137,1.03 [0.97-1.08],0.3532250737026998
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Candidiasis,19990,294,0.98 [0.88-1.09],0.7539272392475522
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19401,2831,1.01 [0.98-1.05],0.4142337882547756
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19390,2871,0.99 [0.96-1.03],0.7404211492634845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19813,855,0.99 [0.93-1.06],0.8114179876387575
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19931,66,0.86 [0.69-1.07],0.1759244487515888
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18135,888,0.99 [0.93-1.05],0.6639167166657958
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17479,973,0.98 [0.92-1.04],0.4825674033916729
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17309,197,0.97 [0.85-1.11],0.6393134452122171
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14051,1858,0.98 [0.94-1.03],0.4809047382212772
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17252,326,1.06 [0.96-1.18],0.2737538386063091
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19981,1023,1.00 [0.94-1.06],0.9186050077431692
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,20064,368,0.95 [0.87-1.05],0.3186273640947752
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19354,716,1.03 [0.96-1.10],0.4465431439587903
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20000,986,0.98 [0.93-1.04],0.5406331051130244
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19113,155,1.02 [0.88-1.18],0.8268308963986949
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20099,42,1.13 [0.84-1.51],0.4230719783542979
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,19868,854,0.98 [0.92-1.04],0.4773335979862967
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19919,54,1.18 [0.91-1.52],0.2199885668084749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,20039,98,1.10 [0.91-1.33],0.3246498265775344
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20024,83,1.16 [0.94-1.43],0.1691435686320765
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19027,389,1.08 [0.98-1.19],0.1004418541118173
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18869,231,1.02 [0.91-1.16],0.7198053237319697
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19026,68,0.96 [0.77-1.19],0.6826165940833072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20082,58,0.86 [0.68-1.08],0.1981662038788926
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20051,121,1.05 [0.89-1.25],0.5472045687395473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral warts,19975,45,1.09 [0.83-1.45],0.5303470693799214
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19975,45,1.05 [0.80-1.40],0.7124749191969098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,19840,293,1.01 [0.90-1.12],0.8848226665429704
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20040,42,1.01 [0.76-1.35],0.9306959333471676
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20007,47,1.02 [0.78-1.33],0.8994889795259008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20061,102,1.01 [0.84-1.21],0.9295684349533442
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19780,1378,0.99 [0.94-1.04],0.5638675377930944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of meninges,20098,26,1.13 [0.78-1.63],0.5341491646482002
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20047,57,0.85 [0.68-1.08],0.1868331630148778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20086,64,0.92 [0.73-1.15],0.4556299430970582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Ascending colon,20076,381,0.99 [0.90-1.09],0.7995533992722187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Caecum,20079,288,1.02 [0.91-1.13],0.7846912014495754
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19988,63,1.02 [0.81-1.28],0.8734143721148218
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Descending colon,20073,240,1.05 [0.93-1.18],0.4495311061433304
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,20035,350,0.92 [0.83-1.01],0.0816145241200721
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19994,631,1.01 [0.94-1.09],0.7578200192871914
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Transverse colon,20062,465,1.02 [0.93-1.11],0.6852824621100795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15659,64,0.99 [0.79-1.25],0.9477263522792088
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15657,62,0.89 [0.71-1.12],0.3359270423848333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20071,80,0.93 [0.76-1.14],0.4685400694474726
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",20071,77,0.93 [0.76-1.15],0.4996841879929141
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lung cancer and mesothelioma,13405,302,1.04 [0.93-1.15],0.502839606029148
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lymphoid leukaemia,15653,58,0.99 [0.78-1.26],0.9345092352145828
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15754,159,1.17 [1.01-1.36],0.0411316397782096
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15830,235,0.99 [0.88-1.12],0.8551821306381238
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15671,76,0.85 [0.69-1.04],0.106945948741892
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15710,115,1.04 [0.87-1.23],0.6797197698855078
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15723,128,1.00 [0.84-1.17],0.9621303891936654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15662,67,1.00 [0.80-1.26],0.9948100076998933
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16741,1146,0.96 [0.91-1.02],0.157339224504191
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15716,121,0.90 [0.77-1.07],0.233996278935946
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15690,95,1.08 [0.89-1.31],0.4506637539460434
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15698,103,1.10 [0.91-1.32],0.3367827990165929
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,19998,142,0.96 [0.82-1.12],0.561526252715732
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of trunk,20073,83,1.03 [0.84-1.27],0.7474451979729342
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanoma in situ,15623,63,1.15 [0.91-1.47],0.2443244281675367
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15684,89,0.93 [0.77-1.13],0.4514148562082082
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15738,143,0.89 [0.77-1.04],0.1403459617514257
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15790,195,1.04 [0.91-1.19],0.5626787145381962
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15684,89,0.89 [0.73-1.08],0.2296227110134881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,19991,123,1.01 [0.85-1.19],0.9184245746199476
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16602,1007,0.96 [0.91-1.02],0.1964816824139088
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16662,1067,0.97 [0.92-1.03],0.3520109697335666
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19877,244,0.98 [0.87-1.10],0.7052682836193667
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18675,65,1.16 [0.92-1.47],0.2033678099360856
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19689,56,1.10 [0.86-1.42],0.453100086861691
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19657,2268,1.01 [0.97-1.05],0.6256459820605031
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19066,51,1.52 [1.15-2.02],0.0033837087200541
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19746,43,0.91 [0.69-1.19],0.4822669128705938
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19807,1197,1.02 [0.97-1.08],0.4317161668224283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19805,1195,1.02 [0.97-1.08],0.4751447900630196
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18686,76,0.89 [0.72-1.09],0.2584056877567454
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19915,900,1.08 [1.01-1.15],0.0191231483889323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19794,91,1.06 [0.87-1.29],0.5681180048753149
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19690,57,0.95 [0.74-1.22],0.6877605075598211
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19686,53,1.16 [0.89-1.50],0.2767634158750862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19961,258,0.77 [0.69-0.86],4.0428000528986844e-06
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20019,38,0.96 [0.71-1.30],0.7958405382346566
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19912,209,0.73 [0.64-0.82],1.702377851369119e-07
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19076,61,0.81 [0.65-1.03],0.0811114095012487
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14899,300,0.96 [0.86-1.06],0.4132234840620423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18379,131,1.16 [0.98-1.37],0.0905648102722635
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18409,161,1.00 [0.86-1.15],0.978999292184444
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14650,51,1.15 [0.88-1.50],0.3062175829664789
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18977,54,0.89 [0.70-1.14],0.3589340027944351
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18328,188,0.93 [0.82-1.07],0.3222704412191698
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19710,473,0.99 [0.91-1.08],0.8373166286353677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19433,196,0.91 [0.80-1.04],0.1645641967091387
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19355,118,1.10 [0.92-1.31],0.2933437578860809
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19851,928,1.08 [1.02-1.15],0.0141032880688104
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17241,894,1.07 [1.00-1.14],0.0423990035229723
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14657,58,0.83 [0.65-1.05],0.1218985311804025
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19384,36,1.09 [0.79-1.48],0.6088744760020255
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14813,214,1.08 [0.95-1.23],0.2436638906775458
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14659,60,0.99 [0.78-1.26],0.9596081859916672
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17819,3220,1.05 [1.01-1.08],0.0064484408162194
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14748,149,0.96 [0.82-1.11],0.579386048513839
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15050,451,1.03 [0.95-1.13],0.4711630282419459
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20050,221,0.97 [0.86-1.10],0.6757691422086041
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19899,70,0.82 [0.66-1.01],0.0657244224022953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14723,124,1.06 [0.90-1.25],0.4976245319917733
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14654,55,0.90 [0.70-1.14],0.3769151093292707
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19945,597,1.04 [0.96-1.12],0.3722321809218084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14851,252,1.07 [0.95-1.21],0.2396549553238947
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14885,286,0.84 [0.75-0.93],0.0009610518299859
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15202,603,1.09 [1.01-1.17],0.0320466613431799
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14711,112,0.90 [0.76-1.07],0.2534576700007384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19893,64,0.81 [0.65-1.01],0.0614493512940876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15089,490,1.08 [0.99-1.17],0.091443828046635
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14925,326,1.02 [0.92-1.13],0.7615531151880158
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18188,48,1.08 [0.82-1.42],0.5766682953202013
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18932,4333,1.03 [1.00-1.06],0.0669811887009109
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19360,12,1.15 [0.66-1.99],0.6266465824157492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19369,21,1.17 [0.77-1.77],0.4695936214137679
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19963,1489,0.98 [0.93-1.03],0.3775619841788313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19959,1484,0.98 [0.93-1.03],0.3943972940283839
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19362,14,1.74 [1.01-3.00],0.0472069218353229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19875,672,1.01 [0.94-1.08],0.8144636689822476
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15939,1340,1.00 [0.95-1.06],0.8726746658047556
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20090,198,0.83 [0.73-0.95],0.0049767467974954
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19321,84,0.86 [0.71-1.04],0.1281974321758408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19265,62,1.03 [0.82-1.31],0.7896604906381584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19276,73,1.20 [0.96-1.51],0.1051009646231164
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14657,58,1.10 [0.86-1.41],0.4441574670972257
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17752,144,1.04 [0.89-1.21],0.62253473582966
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2132,103,0.97 [0.81-1.16],0.7612617738435286
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2268,265,0.96 [0.86-1.07],0.4463203997065411
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17690,82,1.08 [0.88-1.33],0.4548797058040291
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2085,56,0.85 [0.67-1.08],0.1848639610305612
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19456,1848,1.04 [1.00-1.09],0.0557879998606882
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19511,274,0.88 [0.79-0.98],0.024252160772193
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18338,198,0.90 [0.79-1.03],0.1142657803969843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15232,633,0.97 [0.91-1.05],0.4867332630926856
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19991,207,0.92 [0.81-1.05],0.2210300588560169
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19095,231,0.93 [0.82-1.05],0.224265454849741
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,17691,1240,0.98 [0.93-1.03],0.4649497422188008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Aortic aneurysm,19191,327,0.94 [0.85-1.04],0.2599868862667688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18929,65,1.16 [0.92-1.47],0.2097137431388834
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19053,189,1.11 [0.97-1.27],0.1421152893325784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11778,1911,0.95 [0.91-0.99],0.0236014293501932
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,AV-block,16218,501,0.95 [0.88-1.03],0.2420539677217033
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20040,435,0.99 [0.91-1.08],0.8724648443638812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiac arrest,10078,211,1.01 [0.89-1.15],0.876596637567838
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,15887,170,0.93 [0.81-1.07],0.2909311385292667
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15807,90,0.91 [0.75-1.10],0.3142485288293992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20099,48,1.01 [0.77-1.32],0.9494050334797632
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,16842,1125,0.96 [0.91-1.01],0.1213435153934079
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18636,2205,1.02 [0.98-1.06],0.4449718153954692
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17013,6585,1.01 [0.99-1.03],0.4712625008476637
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,19061,228,0.91 [0.81-1.03],0.1255742607041251
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Endocarditis,15787,70,0.89 [0.72-1.11],0.2994749095209293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",19836,1107,1.02 [0.96-1.08],0.5483752107439056
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,18012,5720,1.03 [1.00-1.05],0.0360764272055962
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",18017,5725,1.03 [1.00-1.05],0.0385386129843796
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, portal",19903,99,0.85 [0.71-1.02],0.0730586437207385
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12463,171,1.02 [0.89-1.18],0.745088764051008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12397,105,1.00 [0.83-1.20],0.9933838996562672
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,19976,996,1.04 [0.98-1.10],0.1891231513956081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19218,97,0.88 [0.74-1.06],0.1718673300388614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18752,2301,1.00 [0.97-1.04],0.8695427132193185
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19755,548,1.09 [1.00-1.18],0.0442874785087825
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Left bundle-branch block,16060,343,0.99 [0.89-1.09],0.7987773391177586
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19515,896,1.03 [0.97-1.09],0.3824154458799333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17228,777,1.04 [0.97-1.11],0.2534024805612858
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19962,194,1.03 [0.90-1.17],0.7032074730797968
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20056,315,1.04 [0.94-1.16],0.4232463936018273
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Oesophageal varices,18887,54,0.79 [0.63-1.00],0.0522278735327589
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other aneurysm,18943,79,1.10 [0.89-1.36],0.3594015575792699
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,16121,404,0.97 [0.89-1.06],0.5196413251738262
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18971,107,1.05 [0.88-1.25],0.5959671720564417
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19087,223,1.00 [0.88-1.13],0.987111895380384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15873,156,1.04 [0.90-1.21],0.6043095567465855
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other disorders of veins,18910,77,0.95 [0.77-1.18],0.6558984182057114
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18875,42,1.06 [0.80-1.42],0.6797784494996507
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18810,73,1.06 [0.85-1.32],0.5885771169611673
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18920,87,0.97 [0.79-1.18],0.7565912716098961
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16749,1032,0.98 [0.92-1.04],0.4519939821658062
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19035,55,0.88 [0.69-1.12],0.3006714096801893
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19332,468,1.07 [0.98-1.17],0.1087803412709731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19557,320,1.06 [0.95-1.18],0.2835518531787742
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19277,540,1.04 [0.96-1.13],0.3102912995974644
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10177,310,0.95 [0.86-1.06],0.3404863440207372
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,19250,429,1.08 [0.99-1.18],0.0884410866158827
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19125,292,0.93 [0.83-1.03],0.1605868744473875
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,19647,410,0.97 [0.89-1.06],0.5224805850211316
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20047,589,1.02 [0.94-1.10],0.6515374559536518
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Right bundle-branch block,16113,396,0.93 [0.85-1.02],0.1352962838890659
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,19556,319,1.05 [0.95-1.17],0.328297970369344
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18918,181,1.05 [0.91-1.21],0.4841419080882876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19743,622,1.07 [0.99-1.15],0.0927543001697991
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19732,646,1.06 [0.99-1.14],0.1035271872104955
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19201,37,0.95 [0.70-1.28],0.7261363193794315
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18958,95,0.86 [0.71-1.03],0.0998920350191693
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,19403,196,1.07 [0.94-1.23],0.2995906681845495
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18876,257,1.02 [0.91-1.14],0.7699429430182894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,19153,320,0.96 [0.87-1.07],0.4525338729703325
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18880,59,0.94 [0.74-1.19],0.6187288593547274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,19890,641,0.95 [0.88-1.02],0.1284920264705686
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19931,415,0.99 [0.91-1.09],0.9025820601609932
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17332,813,1.04 [0.97-1.11],0.2660574338344016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,19519,3000,1.01 [0.98-1.05],0.432524201955609
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19878,483,1.00 [0.92-1.09],0.9324536825083944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17479,960,1.05 [0.99-1.12],0.0874269883525447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16582,63,1.14 [0.90-1.44],0.2855150151802543
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,19541,1287,1.00 [0.95-1.05],0.962673195744058
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18077,1558,1.00 [0.96-1.05],0.8916050895922737
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Vascular dementia,19714,116,0.89 [0.76-1.06],0.1955858946261457
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Alzheimer disease,20099,245,0.94 [0.83-1.05],0.2709066059972881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13465,49,0.95 [0.73-1.23],0.6862262139623816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Bell's palsy,18950,67,1.03 [0.82-1.29],0.810747451257404
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19174,291,1.07 [0.96-1.19],0.2442688986186745
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral cysts,19765,190,0.97 [0.85-1.11],0.6533751014818576
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20027,287,0.98 [0.88-1.09],0.7017481771198903
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19695,55,1.16 [0.90-1.50],0.2605860849967487
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20084,66,0.80 [0.65-1.00],0.0488524237105693
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19649,74,0.97 [0.78-1.20],0.7964818647362618
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,18762,234,0.96 [0.85-1.08],0.4734626254147307
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19653,1125,1.04 [0.98-1.10],0.1787564077817614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20066,397,0.95 [0.87-1.04],0.2858787696276569
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,19638,1779,0.95 [0.91-0.99],0.0223018327380379
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Generalized epilepsy,19778,49,1.06 [0.81-1.38],0.670179913477182
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,19963,223,1.02 [0.90-1.15],0.7721146542948925
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hydrocephalus,19624,49,1.00 [0.77-1.31],0.9822145677103672
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20084,53,1.24 [0.96-1.62],0.1055405577879749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18902,19,0.81 [0.54-1.22],0.32374375291958
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18960,77,0.91 [0.74-1.12],0.3951788179059653
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Memory loss,19583,105,0.87 [0.73-1.04],0.1345383677714212
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,18689,161,1.18 [1.02-1.37],0.0297159787903601
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20081,147,1.19 [1.02-1.40],0.0293208214267276
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Motor neuron disease,13567,139,1.07 [0.91-1.25],0.4218065921958188
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19997,59,0.86 [0.68-1.08],0.2003800293299662
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19696,813,1.04 [0.98-1.11],0.2289079035992913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,18984,2964,1.01 [0.98-1.05],0.5577890215549285
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19824,184,1.01 [0.89-1.16],0.8354079624679733
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19193,310,1.04 [0.94-1.16],0.4595685315930157
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20024,296,1.02 [0.92-1.14],0.6675343348955473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15880,509,0.98 [0.90-1.06],0.6546877558281915
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19635,60,0.77 [0.61-0.97],0.025899812827492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other disorders of nervous system,19700,125,0.97 [0.83-1.15],0.748373693221893
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19779,110,0.99 [0.83-1.18],0.9223334167913102
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other facial nerve disorders,18967,84,0.99 [0.81-1.22],0.948279295494496
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other headache syndromes,18562,34,0.96 [0.70-1.31],0.7872296284540539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,20001,426,0.97 [0.89-1.06],0.5011862949284637
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,19107,579,1.05 [0.97-1.13],0.2283742465068885
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Parkinson's disease,20078,267,0.92 [0.83-1.03],0.1573346801846293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19598,23,0.85 [0.59-1.24],0.4007024263035478
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Restless leg syndrome,20098,37,1.15 [0.84-1.57],0.3820094192757034
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,19853,524,1.06 [0.98-1.15],0.1763734493642596
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Small fibre neuropathy,19777,49,0.99 [0.76-1.29],0.9344549067628074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20082,158,1.07 [0.92-1.24],0.3990969432325378
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18911,28,1.09 [0.76-1.56],0.6366972119638243
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20099,248,0.94 [0.83-1.05],0.2620676158047429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19686,112,0.89 [0.75-1.05],0.1678798745284596
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19656,69,1.02 [0.81-1.27],0.8960665271977014
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19807,241,0.98 [0.87-1.10],0.7325740744261888
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19949,247,0.97 [0.86-1.08],0.5563042367131354
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19357,40,0.83 [0.63-1.10],0.1878653193349533
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19371,54,1.24 [0.95-1.60],0.1111136369374422
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20021,34,0.99 [0.71-1.36],0.9346071807187716
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19912,101,1.07 [0.89-1.29],0.4962663855418917
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2085,56,0.84 [0.67-1.07],0.1554890517176488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2539,108,0.99 [0.83-1.18],0.9135468863941238
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19667,80,1.31 [1.05-1.62],0.0156432651967912
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19911,843,1.01 [0.94-1.07],0.8745877366368613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19841,524,0.97 [0.90-1.05],0.5125279525543436
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19430,113,1.01 [0.85-1.20],0.9233811419738898
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20036,470,1.00 [0.91-1.08],0.9174752604163128
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20097,55,1.11 [0.86-1.43],0.4256950992451787
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19984,418,1.00 [0.91-1.09],0.9399567243934877
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20066,255,1.00 [0.89-1.12],0.9952934650109988
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20023,132,1.07 [0.91-1.27],0.3859677462676437
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19384,67,1.14 [0.90-1.44],0.2763530082540229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19393,76,0.87 [0.71-1.06],0.1690838800970144
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19351,34,0.95 [0.69-1.30],0.7481756725153503
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20019,572,0.96 [0.89-1.04],0.3333058167171201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19611,164,0.92 [0.79-1.06],0.2347429068533913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19589,23,0.74 [0.52-1.07],0.1089982465305614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19892,81,0.96 [0.78-1.17],0.6573764047752719
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19990,179,0.99 [0.86-1.13],0.859221321994013
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19716,150,1.05 [0.90-1.22],0.5655527544770598
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19961,70,1.08 [0.87-1.36],0.4802848968829225
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19819,372,1.02 [0.92-1.12],0.7193126822902391
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19685,98,1.18 [0.97-1.43],0.0977988941714065
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18968,1494,1.01 [0.96-1.06],0.6130995630636574
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19966,155,0.98 [0.85-1.14],0.8265153651984473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20084,119,1.07 [0.90-1.27],0.4200303092485095
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19683,366,0.95 [0.86-1.04],0.2881558998377997
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19869,58,0.92 [0.73-1.17],0.5105126712314523
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20087,45,1.07 [0.81-1.41],0.6465662823272809
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19377,60,0.89 [0.71-1.13],0.3448040517465863
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19444,127,0.89 [0.76-1.04],0.1505557085019692
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19174,106,1.03 [0.86-1.23],0.740640550985455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19603,37,0.87 [0.65-1.18],0.3750841697042626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19123,55,0.88 [0.69-1.12],0.2869640389060501
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19488,41,0.79 [0.60-1.04],0.093095130570338
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19618,171,0.98 [0.85-1.13],0.7721911178319563
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19414,97,1.00 [0.83-1.21],0.9737218985038858
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19175,107,1.27 [1.06-1.54],0.0114114590331778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19143,75,0.96 [0.78-1.19],0.7287972851473556
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18675,1201,1.00 [0.95-1.06],0.8734801275924864
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19364,47,0.91 [0.70-1.18],0.4795510459768499
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19902,315,1.16 [1.04-1.29],0.0064895921261172
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19647,60,1.17 [0.91-1.49],0.214339545659361
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19710,123,0.92 [0.78-1.08],0.3014388345384053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19944,52,0.87 [0.67-1.11],0.2647231241121037
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20063,108,1.07 [0.90-1.29],0.4323251252308444
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19984,95,1.17 [0.96-1.42],0.1218167022967074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19937,45,0.95 [0.72-1.24],0.6858081287835418
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19935,43,1.10 [0.83-1.47],0.4974137098245382
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20014,787,1.04 [0.97-1.11],0.279297612767688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19811,584,1.03 [0.96-1.12],0.3881534748586245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19334,107,0.91 [0.76-1.08],0.291659521772959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19297,70,1.19 [0.95-1.49],0.1359961204276001
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute pharyngitis,19913,46,0.98 [0.75-1.28],0.8777936719445592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20025,158,1.02 [0.88-1.18],0.8301871745605741
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19919,52,0.85 [0.66-1.09],0.1922439791136551
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza,18212,85,1.04 [0.85-1.27],0.6910533868423084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18209,82,1.08 [0.88-1.32],0.4885416732103859
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic asthma (mode),13189,86,1.08 [0.88-1.32],0.4560475308862131
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic rhinitis,20011,230,1.00 [0.89-1.13],0.9507064231537362
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14030,1216,1.05 [0.99-1.10],0.0922133401788101
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14295,1192,1.05 [0.99-1.11],0.0842908487406201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19766,123,1.10 [0.93-1.30],0.2808663977719663
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18202,75,1.16 [0.93-1.45],0.1847820901722077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bronchiectasis,17455,244,1.05 [0.93-1.19],0.3951644343469248
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17247,36,1.43 [1.03-1.98],0.0349209500501629
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19373,2162,1.03 [0.99-1.08],0.0980110729592845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18864,66,1.10 [0.87-1.39],0.4337682506931843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,18927,129,1.10 [0.93-1.30],0.2563531081122295
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19910,1097,1.00 [0.95-1.06],0.9995537272482868
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,18922,124,0.98 [0.83-1.16],0.8150559290797101
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18392,4411,1.02 [0.99-1.05],0.1615941055653062
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19137,339,1.01 [0.91-1.12],0.8402654338386595
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,19084,271,0.95 [0.85-1.06],0.359022067243485
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Emphysema,17518,307,1.02 [0.92-1.13],0.7059994097196877
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19299,301,1.03 [0.92-1.14],0.6386218324668327
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,19889,1762,1.01 [0.97-1.06],0.6618996550293943
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,19321,323,1.06 [0.95-1.17],0.287559320733558
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Later onset COPD,19158,826,1.02 [0.96-1.09],0.4970668152613986
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20083,331,1.05 [0.95-1.16],0.3669933781514671
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,18929,131,1.00 [0.85-1.18],0.9749051753133776
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19866,815,1.04 [0.98-1.11],0.2177247624726461
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,19866,1839,1.05 [1.00-1.10],0.0301716597303499
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19543,745,1.01 [0.94-1.08],0.7514476252187745
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other pleural conditions,18077,50,0.93 [0.72-1.21],0.606768860977231
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20004,393,1.02 [0.93-1.12],0.6959619708425226
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19997,1171,1.07 [1.01-1.13],0.0168269904338825
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,18954,927,1.02 [0.96-1.08],0.5417874599904743
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural plaque,18252,225,1.00 [0.89-1.13],0.971176564288365
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19677,1550,1.01 [0.96-1.06],0.761910657983268
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19997,245,1.10 [0.97-1.24],0.1262619331976333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumothorax,18148,121,0.99 [0.83-1.16],0.8679908575827892
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pollen allergy,20085,199,1.06 [0.93-1.21],0.3971004414647002
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pulmonary oedema,19668,57,0.81 [0.64-1.03],0.0825989702323925
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Respiratory insufficiency,13154,51,1.28 [0.97-1.68],0.0801065154516959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19850,799,1.04 [0.97-1.11],0.2288030017575886
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19029,231,1.01 [0.89-1.14],0.9093099631110402
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Viral pneumonia,18350,223,1.00 [0.88-1.13],0.9979131880767316
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19786,190,0.98 [0.85-1.12],0.7221761676199661
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8805,96,0.97 [0.80-1.17],0.7440721417674194
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14080,72,1.02 [0.82-1.27],0.8793211086498965
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,19988,118,1.05 [0.89-1.25],0.5475281451504901
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute gastritis,15228,72,1.08 [0.87-1.35],0.4750508206459594
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,18945,173,0.92 [0.80-1.06],0.2443810798939407
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute peritonitis,19791,78,0.94 [0.77-1.16],0.574892374638801
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Alcoholic liver disease,19339,94,0.81 [0.67-0.97],0.0205321493383136
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Barrett oesophagus,15599,443,0.97 [0.89-1.06],0.5467274865735567
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18875,103,0.96 [0.80-1.15],0.6601432131841816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19758,103,0.96 [0.80-1.15],0.6300022285541991
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,18957,185,0.93 [0.81-1.06],0.2838550575327148
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,19459,687,1.04 [0.97-1.11],0.3172269455628844
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,15376,220,0.93 [0.82-1.05],0.2403091767645983
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic pancreatitis,18819,47,0.91 [0.70-1.19],0.50128417580824
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19923,119,0.84 [0.71-0.99],0.0337699169009816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,18731,74,1.19 [0.95-1.48],0.1352107850600257
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Collagenous colitis,18883,40,0.99 [0.74-1.33],0.952500676356109
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19956,183,0.88 [0.77-1.01],0.0677364710850045
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,19958,1299,0.99 [0.94-1.04],0.7817630715896209
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,18919,76,1.02 [0.82-1.26],0.8629981199136458
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19807,55,1.00 [0.78-1.28],0.9776086006907564
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,18907,64,1.07 [0.84-1.35],0.5870252436509007
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,19556,185,1.07 [0.93-1.23],0.3441957124612713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17035,1628,1.00 [0.96-1.05],0.9835977332598408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,20013,143,1.02 [0.87-1.18],0.8488805153632827
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,19980,735,0.94 [0.88-1.01],0.0940747845299411
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18406,3250,1.01 [0.98-1.05],0.3928360614625139
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19791,420,1.07 [0.97-1.17],0.1648813000089818
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,20061,348,1.01 [0.91-1.11],0.8990034311909423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19458,87,1.18 [0.96-1.44],0.1202242620527449
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of salivary glands,19348,51,1.14 [0.87-1.48],0.3373959336472377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,19834,1177,1.01 [0.96-1.07],0.5920255647901153
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of tongue,19357,93,1.04 [0.86-1.26],0.6942316558617191
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19803,1031,1.00 [0.94-1.06],0.9862337187533478
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16580,2572,0.98 [0.94-1.01],0.2041622764026721
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,15370,214,1.00 [0.88-1.13],0.977489700581632
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19998,166,1.04 [0.90-1.20],0.6056651796481927
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20042,34,1.33 [0.95-1.87],0.0966199507775736
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19382,137,0.87 [0.74-1.01],0.0663852719808003
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14156,148,0.89 [0.77-1.04],0.1378578492085459
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,15508,352,0.98 [0.89-1.08],0.7381404417628454
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,15462,306,1.03 [0.93-1.15],0.5665284845741793
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16954,1798,1.02 [0.98-1.07],0.3873488407066368
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15646,490,1.02 [0.94-1.11],0.6118918972716461
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15372,6690,1.00 [0.98-1.03],0.7119635354643756
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,19631,974,0.99 [0.94-1.05],0.8081761000877137
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19416,45,1.06 [0.80-1.40],0.6874564126839604
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14790,1015,0.94 [0.89-1.00],0.0502728952356489
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19316,71,0.93 [0.75-1.15],0.4963547985442074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,18364,2957,1.02 [0.98-1.05],0.2802817951189685
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,20045,33,1.39 [0.98-1.96],0.0613184670781052
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impaction of intestines,14046,38,0.83 [0.62-1.11],0.2131868078683024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,16784,1377,1.04 [0.99-1.09],0.1665503944509347
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15570,163,1.00 [0.86-1.15],0.966714751406598
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14083,75,0.87 [0.71-1.08],0.1997572136002776
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,18744,87,1.15 [0.94-1.41],0.173109609369617
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14243,235,0.95 [0.84-1.07],0.4081499823737141
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20062,315,1.00 [0.90-1.11],0.9926068076328952
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19410,567,1.00 [0.93-1.09],0.908507724342634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19588,745,0.98 [0.92-1.05],0.6048968770566602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,15331,175,0.93 [0.81-1.07],0.3041264940697193
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,15682,526,1.05 [0.97-1.14],0.2524703324117452
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20051,94,1.09 [0.89-1.32],0.4114494392739687
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15464,57,1.28 [0.99-1.65],0.0620622160260629
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15212,1204,1.00 [0.95-1.05],0.9695225003244444
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18990,218,0.94 [0.83-1.06],0.3136647049341468
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18875,103,0.98 [0.82-1.18],0.8456448510934489
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,15597,1589,0.98 [0.93-1.02],0.329165793724421
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,18559,4551,0.97 [0.94-1.00],0.032512278788591
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19328,153,1.11 [0.95-1.29],0.192234486797423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,19835,590,0.92 [0.86-1.00],0.037710286404018
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15776,620,0.98 [0.91-1.05],0.5797192697796708
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of pancreas,18885,113,0.94 [0.79-1.12],0.4774122594353031
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20004,291,1.04 [0.93-1.16],0.4789580634473278
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15821,665,0.98 [0.91-1.05],0.6102114458830525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19640,983,0.99 [0.94-1.05],0.7843817166696792
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19516,145,1.04 [0.89-1.22],0.594323251877009
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15337,1329,0.98 [0.93-1.03],0.4187626959418993
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16724,1568,0.99 [0.94-1.03],0.5855583775544828
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19325,80,0.82 [0.67-1.00],0.0515134582698203
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19493,650,0.98 [0.91-1.05],0.5086045464231899
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14299,291,0.97 [0.87-1.08],0.6020053424816233
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20033,42,1.28 [0.95-1.74],0.1062021557219084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14402,394,0.95 [0.87-1.04],0.2909659670636702
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18799,142,1.12 [0.95-1.31],0.1729099709685563
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Recurring oral aphthae,20085,34,0.93 [0.68-1.28],0.6679579046630819
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19376,80,1.13 [0.91-1.40],0.2615448055436264
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Toxic colitis,18881,38,0.72 [0.54-0.96],0.0251678647111728
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15414,258,1.02 [0.91-1.15],0.6818750779645584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,18969,126,1.03 [0.87-1.22],0.7128347005792106
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18947,104,1.00 [0.84-1.20],0.9778966142335764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,15708,301,0.97 [0.87-1.08],0.5900019259324845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14139,131,0.94 [0.80-1.10],0.44252155202171
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,15623,216,1.07 [0.94-1.21],0.3045667204880387
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Volvulus,14066,58,0.91 [0.72-1.16],0.4379907172461645
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20045,273,0.96 [0.86-1.07],0.4655109577120938
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19835,58,1.15 [0.89-1.47],0.282296564863446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18465,76,0.95 [0.77-1.17],0.6161071536913161
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19476,639,0.96 [0.89-1.03],0.2499385633755786
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19007,170,1.04 [0.90-1.19],0.6237810090386353
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18753,364,0.95 [0.86-1.05],0.301204834486086
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19854,226,1.08 [0.96-1.23],0.2129209996883591
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20016,388,1.06 [0.96-1.17],0.2231396496113814
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19667,39,1.21 [0.89-1.64],0.2207646618785033
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18835,2627,0.98 [0.95-1.02],0.2704119139744877
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19711,335,0.97 [0.88-1.07],0.5492122361742641
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19613,237,0.95 [0.84-1.07],0.4162609766765762
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19701,864,0.97 [0.91-1.04],0.3886722623570355
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20089,24,1.03 [0.69-1.51],0.8979087485000808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18412,23,1.38 [0.92-2.08],0.1199485836561971
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19428,52,0.95 [0.73-1.22],0.6678733509080512
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19850,222,1.07 [0.95-1.22],0.2613794950991934
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18789,400,0.96 [0.88-1.05],0.3933528311406581
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18455,66,0.85 [0.68-1.06],0.1473580785548362
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20042,71,1.06 [0.85-1.33],0.6037856635216362
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19003,166,1.08 [0.94-1.25],0.287056184585942
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19957,180,1.05 [0.92-1.21],0.4737889250415315
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19686,58,0.91 [0.72-1.16],0.4548641744866124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18442,53,0.86 [0.67-1.10],0.2399643564016839
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19715,1326,0.97 [0.92-1.02],0.1788476852596212
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18824,435,0.97 [0.89-1.06],0.4779868644947015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18458,69,0.87 [0.70-1.08],0.2191179851600727
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20024,247,1.08 [0.96-1.22],0.192407873028906
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19671,43,1.15 [0.86-1.53],0.3496804190286829
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19994,217,1.10 [0.97-1.25],0.146079668369422
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20061,289,0.95 [0.85-1.05],0.3208205047124821
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18461,72,0.97 [0.78-1.21],0.8142626659270907
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18610,221,0.90 [0.79-1.01],0.0848369091130042
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20055,283,0.95 [0.85-1.06],0.3587186247575753
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18597,208,0.99 [0.87-1.13],0.8981208357995925
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20076,105,1.12 [0.93-1.35],0.2271239627463919
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17335,69,0.93 [0.75-1.15],0.4853064278097392
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18335,3996,1.03 [1.00-1.06],0.0428677348870493
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17148,2809,1.02 [0.99-1.06],0.2561374967124118
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17329,63,1.00 [0.79-1.26],0.987288572006138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17689,119,1.03 [0.87-1.22],0.7541742268839157
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17687,117,1.07 [0.90-1.27],0.4436360193368313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19927,54,0.98 [0.76-1.26],0.8808098794671574
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17633,63,0.90 [0.71-1.13],0.349128722118983
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15070,731,1.06 [0.99-1.14],0.0865900878591169
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19999,124,1.01 [0.86-1.20],0.8717313595349092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17789,219,1.03 [0.91-1.17],0.6664444518752304
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17112,5239,1.03 [1.00-1.05],0.0439692447135453
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19230,85,0.83 [0.68-1.01],0.0565570777676703
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17402,136,0.85 [0.73-1.00],0.0447989535246911
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17642,376,1.07 [0.97-1.17],0.1899575316618295
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19402,1832,1.00 [0.95-1.04],0.8661695826957629
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17582,316,0.99 [0.89-1.10],0.8115102666571483
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17311,45,1.36 [1.02-1.82],0.0383252487385766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17347,81,0.99 [0.81-1.22],0.9321330696168184
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19828,26,1.15 [0.79-1.68],0.450397437148998
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15546,1207,1.01 [0.96-1.07],0.6409411396772858
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15148,809,1.06 [0.99-1.13],0.1022795157919712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19979,797,1.06 [0.99-1.14],0.0718224623701232
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14377,38,0.81 [0.60-1.08],0.1480901634035407
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14406,67,1.05 [0.83-1.32],0.691044706479471
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17485,219,1.05 [0.92-1.19],0.4809423875118394
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14866,527,1.04 [0.96-1.13],0.314986351059444
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17604,34,1.18 [0.85-1.64],0.3154176314873676
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18006,436,0.95 [0.87-1.04],0.257977741948537
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17785,215,1.02 [0.89-1.15],0.8137426466768545
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14830,491,1.02 [0.94-1.11],0.6547775813278397
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17319,53,1.19 [0.91-1.54],0.2029189570719147
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17307,41,1.03 [0.77-1.38],0.8283643086992982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19222,77,0.96 [0.78-1.18],0.7137571756682763
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19859,714,0.95 [0.88-1.01],0.1082024407192049
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19471,326,0.91 [0.82-1.00],0.0563079458995917
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20034,244,1.11 [0.98-1.25],0.0960132861623323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15899,1560,1.03 [0.99-1.08],0.1792446928132108
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14385,46,0.95 [0.72-1.24],0.6875114085274886
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17331,65,1.01 [0.80-1.28],0.9216200772703768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14385,46,0.95 [0.72-1.25],0.7097614924044633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14377,38,0.95 [0.71-1.29],0.762241403843242
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19298,153,0.99 [0.85-1.15],0.9316829139860984
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19282,137,0.96 [0.82-1.12],0.6027884631702471
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20070,69,1.08 [0.86-1.35],0.4940135849197221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18829,1259,0.99 [0.94-1.04],0.7592058946152116
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17319,53,1.22 [0.93-1.59],0.1443321816992969
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14374,35,1.11 [0.80-1.53],0.5359946669877282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18085,515,1.02 [0.94-1.11],0.5723791016076678
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15764,1425,1.05 [1.00-1.10],0.0689293134717097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19847,45,1.36 [1.01-1.82],0.0405177406609166
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20086,52,1.19 [0.91-1.55],0.2072423259785037
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17336,70,0.98 [0.78-1.22],0.8361366954667043
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18087,821,1.06 [0.99-1.13],0.0943044814506274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17343,77,0.87 [0.71-1.07],0.1767460752173158
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15362,1023,1.01 [0.95-1.07],0.7442588451319374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19215,70,0.91 [0.73-1.13],0.3950417546531803
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17304,38,1.30 [0.94-1.79],0.1094721937826027
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17662,92,0.98 [0.81-1.19],0.8374402817339148
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17685,419,1.04 [0.95-1.14],0.3750850632391403
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19961,159,1.05 [0.91-1.22],0.5055876660672578
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17976,406,0.98 [0.90-1.07],0.6777523001455925
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20042,241,1.10 [0.97-1.24],0.1247050383980825
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20086,31,1.15 [0.82-1.62],0.4123490404744139
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17395,129,1.05 [0.89-1.23],0.594619239645232
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16500,474,1.08 [0.99-1.18],0.0833386099397497
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17665,399,0.99 [0.90-1.09],0.8724982469034872
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17552,286,0.96 [0.86-1.07],0.4633117687197308
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14364,25,1.19 [0.81-1.76],0.3737139268116797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16239,1900,1.04 [1.00-1.09],0.0497339684944092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14704,365,0.93 [0.84-1.02],0.1271508525724485
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19934,132,1.01 [0.86-1.18],0.9297788135320484
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20038,37,1.04 [0.77-1.41],0.7905471285166854
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18452,35,1.14 [0.83-1.57],0.4186503086137041
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14393,54,1.15 [0.89-1.49],0.2852908588485094
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17643,73,1.05 [0.84-1.31],0.6792707323240657
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14590,251,1.10 [0.98-1.24],0.1056014641925862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17508,242,1.13 [1.00-1.28],0.0510841225114002
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17747,177,1.10 [0.96-1.27],0.1673431883478879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17640,70,0.89 [0.72-1.10],0.2814040851443032
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15980,25,1.45 [0.98-2.16],0.0649128294491525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20088,33,1.16 [0.83-1.61],0.3903920491196819
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17708,442,1.05 [0.96-1.14],0.3183799656378328
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19819,17,1.15 [0.73-1.82],0.5459711568985981
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19185,1919,1.03 [0.99-1.08],0.1484109912266556
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17355,89,1.25 [1.02-1.53],0.0346938322856284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17976,406,1.00 [0.92-1.10],0.9214475126541546
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19192,165,1.05 [0.90-1.21],0.5470331528705588
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17687,117,1.07 [0.90-1.27],0.4693342423411502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18646,1076,1.02 [0.96-1.08],0.5787964051452129
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18239,669,1.03 [0.95-1.10],0.4889796078918623
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17297,31,1.02 [0.73-1.43],0.8855437214200146
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19839,37,1.37 [0.99-1.88],0.0573505521787348
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17373,107,1.26 [1.05-1.52],0.0143005211651432
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17285,19,1.20 [0.77-1.86],0.4180680866795637
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14390,51,0.92 [0.71-1.18],0.5020827751232306
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,19356,1501,0.99 [0.94-1.04],0.6567976652080969
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19705,336,0.98 [0.89-1.08],0.7095130812264729
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19491,122,0.97 [0.82-1.15],0.7528559704837131
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18982,1127,0.95 [0.90-1.00],0.0695542740273007
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19901,46,0.74 [0.57-0.95],0.0189777492454397
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19890,283,0.96 [0.86-1.07],0.4221652696691157
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,17749,172,1.06 [0.92-1.22],0.4248604610548671
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dialysis,17923,68,1.13 [0.90-1.42],0.3076083064273984
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19048,2777,1.01 [0.98-1.05],0.4657706518189204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18173,4653,1.00 [0.97-1.02],0.7540496827340026
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19925,70,0.97 [0.78-1.21],0.7828439874432469
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydrocele,16440,169,1.02 [0.88-1.17],0.826780957878108
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17920,289,1.07 [0.96-1.20],0.2013389711331326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18448,2177,1.01 [0.97-1.06],0.4955996139401492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16465,194,0.91 [0.80-1.04],0.1821458939493113
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17635,58,0.99 [0.78-1.26],0.956118574899664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16371,100,0.89 [0.74-1.07],0.2048536299248359
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20092,52,1.02 [0.79-1.32],0.8849324789198599
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20090,44,0.95 [0.73-1.26],0.7400904726151718
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19405,1828,0.98 [0.94-1.02],0.3714943193897708
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18375,798,0.94 [0.88-1.00],0.05659330593138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20041,434,0.97 [0.89-1.06],0.4757939079882659
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16529,258,1.03 [0.92-1.16],0.6216489909770271
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16507,236,0.97 [0.86-1.09],0.5987362567747649
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16459,188,1.04 [0.91-1.19],0.5675682045964211
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20088,41,0.99 [0.74-1.33],0.9636217922504148
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18800,1223,1.00 [0.95-1.06],0.8851619641743443
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17954,323,1.05 [0.94-1.16],0.381343770605418
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19753,146,1.00 [0.86-1.17],0.9873566327881486
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19907,52,0.84 [0.66-1.07],0.1645515865313643
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16492,221,1.02 [0.90-1.16],0.7394379063191283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19881,2250,0.99 [0.95-1.03],0.5617887215020914
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17686,55,0.96 [0.75-1.23],0.7536178136073982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17970,115,0.92 [0.78-1.09],0.317090325056187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19431,62,1.07 [0.85-1.36],0.5691051640077512
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,17822,245,1.02 [0.90-1.14],0.799869839649711
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,19808,439,0.97 [0.89-1.06],0.5316981780162764
